Question 1

Does Citadel Advisors own BLRX stock?

Accepted Answer

Yes. As of its Q2 2026 13F, Citadel Advisors holds 14,796 shares of BLRX (Bioline RX), worth $45,868.

Question 2

How many shares of BLRX does Citadel Advisors own?

Accepted Answer

As of its Q2 2026 13F, Citadel Advisors holds 14,796 shares of BLRX (Bioline RX).

Question 3

What is Citadel Advisors' BLRX position worth?

Accepted Answer

As of its Q2 2026 13F, Citadel Advisors' BLRX position is worth $45,868.

Question 4

Is Citadel Advisors buying or selling BLRX?

Accepted Answer

In Q2 2026, Citadel Advisors opened a new BLRX position of 14,796 shares.

Question 5

When did Citadel Advisors first buy BLRX?

Accepted Answer

Citadel Advisors first reported BLRX in its Q2 2025 13F and has listed it in 4 quarterly 13F filings.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q2 Latest	New	14,796	-	$45,868	0.0%	$3.12	31
2026-Q1	Exited	0	-100.0%	$0	0.0%	$2.30	0
2025-Q4	Increased	36,651	+265.8%	$104,455	0.0%	$2.77	24
2025-Q3	Decreased	10,020	-33.0%	$37,876	0.0%	$3.78	0
2025-Q2	New	14,954	-	$68,340	0.0%	$4.57	32

BLRX5 quarters

BLRX
5 quarters